Study of AROSOD-1 in Adult Participants With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis Interventions: Drug: ARO-SOD1 Injection; Drug: Placebo: ARO-aCSF1 Injection Sponsor: Arrowhead Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Randomized double-blind personalized N-of-1 clinical trial to test the safety and potential efficacy of TJ-68 for treating muscle cramps in amyotrophic lateral sclerosis (ALS): study protocol for a TJ-68 trial
DiscussionThe study is underway. A personalized N-of-1 trial design is an efficient approach to testing medications that alleviate muscle cramps in rare disorders. If TJ-68 proves safe and efficacious then it may be used to treat cramps in ALS, and help to improve and sustain quality of life.Trial registrationThis clinical trial has been registered with ClinicalTrials.gov (NCT04998305), 8/9/2021. (Source: Trials)
Source: Trials - July 10, 2023 Category: Research Source Type: clinical trials
Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients
Condition: Sporadic and Familial Amyotrophic Lateral Sclerosis Interventions: Drug: FB1006; Drug: Placebo Sponsor: Peking University Third Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials
